EUVIMEDEUVIMED entdecken
Crossref

Strong PD‐L1 expression in granulomatous prostatitis

Dorian Dikov, Maria Koleva iD, Angelina Mollova, Albena Fakirova

The Prostate · 2023-09 · 83 (13) · 1285-1289

DOI: 10.1002/pros.24590 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Prostate, online erschienen am 25.06.2023. Verfasst von Dorian Dikov und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Clinical Pathology, Medical University of Plovdiv, Plovdiv, Bulgaria. Hauptthemen laut MEDLINE: Prostatitis, Prostatic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The expression of programmed cell death ligand protein (PD‐L1) is weakly investigated in non‐tumoral and inflammatory prostatic pathology. The diagnosis of granulomatous prostatitis (GP) rests on the recognition of localized or diffuse epithelioid granulomatous inflammation in prostatic tissue which is frequently difficult by conventional histological observation alone. PD‐L1 expression in GP is not well studied so far.

Methods

We studied PD‐L1 expression in 17 GP cases (9 nonspecific GP, 5 Bacillus Calmette‐Guérin induced prostatitis, 1 prostatic tuberculosis, and 3 cases of postsurgical prostatic granulomas). The control group included 10 radical prostatectomies of patients with high Gleason score prostate adenocarcinoma (PCa) and National Institutes of Health‐category IV prostatitis (high‐grade histologic prostatitis; HG‐HP).

Results

All of the GP cases showed easily visible strong membranous PD‐L1 expression (high levels of combined positive score) in localized and diffuse epithelioid granulomatous prostatic inflammation. None of the control cases showed the presence of significant PD‐L1 expression in inflammatory infiltrates in HG‐HP, tumor parenchyma, and stroma in PCa.

Conclusions

The study presents the first attempt to examine PD‐L1 expression in GP. Granulomatous inflammation in GP is easily identified when stained with PD‐L1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstatitisProstatic NeoplasmsMaleHumansB7-H1 AntigenDiagnosis, DifferentialGranulomaInflammation

Stichwörter der Autor:innen

PD-L1carcinomagranulomatous prostatitislymphoepithelial lesionsprostatitis

Substanzen

B7-H1 Antigen

Autor:innen und Institutionen

  • Department of General and Clinical Pathology, Medical University of Plovdiv, Plovdiv, Bulgaria.
  • Service d'Anatomie et Cytologie Pathologiques, Grand Hôpital de l'Est Francilien, Jossigny, France.
  • Department of Pathology, Military Medical Academy, Sofia, Bulgaria.

ORCID-Profile: Maria Koleva

Zitieren

APA

Dikov, D., Koleva, M., Mollova, A., & Fakirova, A. (2023). Strong PD‐L1 expression in granulomatous prostatitis. The Prostate, 83(13), 1285-1289. https://doi.org/10.1002/pros.24590

Vancouver

Dikov D, Koleva M, Mollova A, Fakirova A. Strong PD‐L1 expression in granulomatous prostatitis. The Prostate. 2023;83(13):1285-1289. doi:10.1002/pros.24590

BibTeX
@article{Dikov2023,
  author = {Dikov, Dorian and Koleva, Maria and Mollova, Angelina and Fakirova, Albena},
  title = {Strong PD‐L1 expression in granulomatous prostatitis},
  journal = {The Prostate},
  year = {2023},
  volume = {83},
  number = {13},
  pages = {1285--1289},
  doi = {10.1002/pros.24590}
}
Kostenlos starten →